Syntel, Inc. (SYNT) Tops Q3 EPS by 17c; Guides FY EPS Above the Street

Syntel, Inc. (NASDAQ: SYNT) reported Q3 EPS of $0.92, $0.17 better than the analyst estimate of $0.75. Revenue for the quarter came in at $253.6 million versus the consensus estimate of $254.61 million.

Syntel, Inc. sees FY2015 EPS of $2.80-$2.90, versus the consensus of $2.75. Syntel, Inc. sees FY2015 revenue of $972-977 million, versus the consensus of $982.15 million.

We are very pleased with Syntel's third quarter performance," said Syntel CEO and President Nitin Rakesh. "Our Healthcare and Life Sciences segment garnered record revenues, aided by the stepped up investments we've made in this strategic industry."

"Our robust digital and automation capabilities and managed services offerings are resonating with customers and helping us access new channels and broaden our market reach," said Rakesh. "We have readied our organization to meet the challenges presented by rapid shifts in the technology landscape, and expect to turn these into profitable growth opportunities."

"Through a relentless focus on innovation and service quality, we strengthened long-term customer relationships this quarter. We also added meaningful new ones that can rely on Syntel as a committed partner to help them navigate change in their businesses."

For earnings history and earnings-related data on Syntel, Inc. (SYNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c